IntuitionLabs
GxP validation and 21 CFR Part 11 compliance services for Snowflake in pharmaceutical environments

Snowflake GxP Validation & Compliance

Risk-based validation, 21 CFR Part 11 compliance mapping, and ongoing compliance monitoring for Snowflake deployments in regulated pharmaceutical and life sciences environments.

Snowflake Compliance Services

We deliver the complete compliance framework that pharmaceutical organizations need to use Snowflake for GxP-regulated data — from initial gap assessment through validation execution to ongoing monitoring.

Foundation
Gap Assessment & Planning
Comprehensive assessment mapping your Snowflake configuration against 21 CFR Part 11, EU Annex 11, and GAMP 5 requirements. Identifies gaps, defines remediation actions, and produces the Validation Plan.
Execution
IQ/OQ/PQ Validation
Full validation lifecycle execution: Installation Qualification, Operational Qualification, and Performance Qualification with formal test protocols, documented evidence, and Requirements Traceability Matrix.
Ongoing
Compliance Monitoring
Continuous audit trail monitoring, quarterly periodic reviews, annual revalidation assessments, and change control support to maintain the validated state across Snowflake platform updates and configuration changes.

21 CFR Part 11 Compliance Mapping for Snowflake

IntuitionLabs maps every requirement of 21 CFR Part 11 against Snowflake's technical controls — access controls, audit trails, data integrity, system validation, and electronic records management. We document which requirements are met natively by Snowflake, which require configuration, and which need additional procedural or technical controls. The result is a formal compliance matrix with evidence references that satisfies FDA auditors.

21 CFR Part 11 compliance matrix mapping FDA requirements to Snowflake technical controls

Risk-Based Validation Under GAMP 5 Second Edition

Our validation approach follows ISPE GAMP 5 Second Edition risk-based methodology. Base Snowflake (Category 4 configured product) receives configuration verification testing, while custom components — data pipelines, Snowpark applications, Cortex AI workflows — are validated as Category 5 custom systems with full functional testing. This focuses validation effort where risk is highest, reducing cost without compromising compliance rigor.

GAMP 5 risk-based validation approach for Snowflake pharmaceutical deployment

EU Annex 11 & International Regulatory Coverage

For pharmaceutical companies operating globally, we map Snowflake against EU Annex 11, PMDA electronic record guidelines, TGA requirements, and WHO GxP guidelines. Our compliance documentation is structured to satisfy inspectors from any major regulatory authority.

International regulatory compliance framework covering FDA, EMA, PMDA, and TGA requirements for Snowflake

Snowflake Compliance Controls We Configure

Role-Based Access Control

Granular RBAC with least-privilege roles, segregation of duties, and documented access matrices that map user roles to data access privileges across all Snowflake databases and schemas.

Learn more

Audit Trail Configuration

Access History, Login History, and Query History configured with appropriate retention periods, monitoring dashboards, and long-term archive exports for GxP audit trail compliance.

Learn more

Data Protection

AES-256 encryption at rest, TLS 1.2+ in transit, customer-managed keys via Tri-Secret Secure, dynamic data masking for sensitive fields, and network policies for access restriction.

Learn more

Change Management

Behavior change management configuration, infrastructure-as-code with version control, CI/CD quality gates, and quarterly review SOPs for Snowflake platform updates.

Learn more

Backup & Recovery

Time Travel (up to 90 days), Fail-safe (7 additional days), cross-region replication for disaster recovery, and documented recovery procedures tested during OQ.

Learn more

User Management

SAML-based SSO, SCIM provisioning, MFA enforcement, unique user accounts (no shared credentials), and automated deprovisioning SOPs for terminated users.

Learn more

Today's business insights

Profitable growth in the AI solutions industry

Our CEO discusses how AI is transforming the pharmaceutical industry and shares key strategies for leveraging AI in drug discovery and development.

More insights on unlock profitable growth in ai solutions
Profitable growth in the AI solutions industry

Snowflake Data Integrity Under ALCOA+

Data integrity in Snowflake for GxP environments must satisfy the MHRA data integrity guidance ALCOA+ principles. IntuitionLabs maps each ALCOA+ attribute to specific Snowflake controls, configuration settings, and procedural requirements — then validates the complete framework during OQ.

Attributable & Legible

User-level authentication, query audit logging, and deterministic data formats ensure all data is traceable and readable.

Contemporaneous & Original

Time Travel maintains timestamped data versions. Immutable micro-partition storage preserves original records.

Accurate, Complete & Enduring

Schema enforcement, pipeline reconciliation, and Fail-safe with cross-region replication ensure data survives intact.

Regulatory Frameworks We Cover

🇺🇸

FDA 21 CFR Part 11

Complete compliance mapping for electronic records and electronic signatures requirements, including system access controls, audit trails, and data integrity provisions.

🇪🇺

EU Annex 11

All 17 sections mapped against Snowflake capabilities — risk management, supplier qualification, data storage, change management, and business continuity.

📋

ISPE GAMP 5

Risk-based validation methodology with appropriate categorization (Category 4 for base platform, Category 5 for custom components), supplier assessment, and lifecycle documentation.

🌐

ICH Q10

Pharmaceutical quality system alignment covering change management, CAPA, management review, and continuous improvement for the Snowflake operating model.

🇬🇧

MHRA Data Integrity

ALCOA+ principle mapping with documented controls for attributability, legibility, contemporaneity, originality, accuracy, completeness, consistency, endurance, and availability.

💻

FDA CSA Guidance

Alignment with FDA Computer Software Assurance guidance for risk-based testing, critical thinking, and reduced documentation burden for lower-risk system functions.

Frequently Asked Questions

Snowflake provides the infrastructure-level controls and certifications that support GxP use, but — like any cloud platform — achieving GxP compliance requires customer-side validation of your specific configuration and use case. Snowflake maintains SOC 1 Type II, SOC 2 Type II, HIPAA (with BAA), HITRUST CSF, FedRAMP High, ISO 27001, and ISO 27018 certifications, and provides a GxP readiness attestation that documents the platform's technical controls against common GxP requirements. However, the FDA has stated that software cannot be validated by the vendor alone — it must be validated in the context of its intended use by the regulated organization. IntuitionLabs bridges this gap by performing the customer-side validation that maps Snowflake's technical controls against your specific GxP requirements, documenting the validation lifecycle from intended use specification through IQ/OQ/PQ execution to ongoing periodic review.
Snowflake provides technical controls that map to the key requirements of 21 CFR Part 11, but each requires proper configuration and documented procedures to achieve compliance. For system access controls (§11.10(d)), Snowflake offers role-based access control (RBAC), network policies, IP allowlisting, and multi-factor authentication via SAML/SCIM integration with enterprise identity providers. For audit trails (§11.10(e)), Snowflake provides Access History for query-level audit logging, Login History for authentication events, and Time Travel for data change tracking — though these must be configured with appropriate retention periods and monitored as part of your SOPs. For data integrity (§11.10(a)), Snowflake's immutable storage architecture, Time Travel, and Fail-safe features prevent unauthorized data modification and enable point-in-time data recovery. IntuitionLabs documents each of these control mappings in a formal 21 CFR Part 11 Compliance Matrix with evidence references, gap identification, and remediation actions for any areas requiring additional configuration or procedural controls.
Under ISPE GAMP 5 Second Edition, Snowflake's classification depends on how it is deployed and customized. The base Snowflake platform — virtual warehouses, standard SQL operations, built-in security features — is typically classified as GAMP Category 4 (configured product), since it is a commercially available product that is configured but not fundamentally altered. Custom components built on Snowflake — Snowpark applications, stored procedures, data pipelines, Cortex AI workflows, and MCP integrations — are classified as GAMP Category 5 (custom applications), requiring more rigorous testing and documentation. Our validation approach applies risk-based testing appropriate to each category: Category 4 components receive configuration verification testing focused on confirming that security, access control, and audit trail settings match the URS, while Category 5 components undergo full functional testing with documented test scripts, expected results, and traceability to requirements. This risk-based approach focuses validation effort where it matters most, in line with GAMP 5's principle that testing rigor should be proportional to system risk and complexity.
Our Snowflake GxP validation engagement produces a complete documentation package that satisfies regulatory audit expectations. Core deliverables include: Validation Plan (VP) defining scope, strategy, roles, and acceptance criteria; User Requirements Specification (URS) documenting business and regulatory requirements; Functional Requirements Specification (FRS) mapping URS to Snowflake capabilities; Risk Assessment using FMEA methodology per GAMP 5 to identify critical functions requiring testing; Configuration Specification documenting all Snowflake settings including RBAC, network policies, encryption, and audit trail configuration; Installation Qualification (IQ) verifying the Snowflake environment matches the design specification; Operational Qualification (OQ) testing all critical functions including access controls, audit trails, data integrity, and backup/recovery; Performance Qualification (PQ) verifying the system meets user requirements under production-like conditions; Requirements Traceability Matrix (RTM) linking every requirement through design, testing, and acceptance; 21 CFR Part 11 Compliance Matrix mapping each Part 11 requirement to Snowflake controls with evidence references; Validation Summary Report documenting testing outcomes, deviations, and final compliance assessment; and Standard Operating Procedures for system administration, change control, user management, and periodic review.
Snowflake releases weekly feature updates and periodic behavior changes, which creates a unique challenge for validated environments that typically require formal change control for any system modification. Our approach implements a sustainable change management framework that balances regulatory compliance with operational reality. We classify Snowflake updates into three categories: transparent updates (performance improvements, UI changes, new optional features) that require monitoring but not revalidation; behavioral updates (changes to default settings, function behavior, or security controls) that require impact assessment and potentially targeted revalidation; and breaking changes (deprecated features, changed APIs) that require formal change control with updated documentation and testing. We configure Snowflake's behavior change management to control when behavioral changes take effect, giving your quality team time to assess impact before changes are applied. Our SOPs include a periodic review process (typically quarterly) that reviews all Snowflake release notes since the last review, assesses impact against the validated configuration, and documents the assessment — satisfying the ongoing monitoring requirement of EU Annex 11 and ICH Q10.
Data integrity in Snowflake for GxP environments is maintained through a combination of platform features and procedural controls aligned with MHRA data integrity guidance and the ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available). Attributability is ensured through user-level authentication (no shared accounts), query-level audit logging via Access History, and session tracking via Login History — every data access and modification is linked to a specific user. Legibility and accuracy are maintained through Snowflake's schema enforcement, data type constraints, and validation rules implemented in data pipelines. Contemporaneity is ensured through Time Travel which maintains time-stamped versions of all data changes for the configured retention period (up to 90 days on Enterprise edition). Originality is preserved through Snowflake's immutable storage architecture — data written to Snowflake micro-partitions cannot be modified in place; changes create new versions. Completeness and consistency are enforced through pipeline reconciliation checks, row count verification, and checksum validation that we build into every data integration. Endurance is provided by Fail-safe (7-day additional recovery beyond Time Travel) and cross-region replication for disaster recovery.
Yes. Data pipeline validation is a critical component of our Snowflake GxP validation program, because the integrity of data in Snowflake depends entirely on the integrity of the pipelines that populate it. We validate data pipelines under GAMP 5 Category 5 (custom applications) with testing that covers end-to-end data flow verification (source record counts match target after extraction, transformation, and loading), data transformation accuracy (calculated fields, date conversions, unit transformations produce expected results), referential integrity (foreign key relationships are maintained across pipeline stages), error handling (the pipeline correctly identifies, logs, and quarantines malformed or unexpected data), reconciliation automation (scheduled jobs verify data completeness and consistency with source systems), and audit logging (every pipeline execution is logged with start time, end time, records processed, records rejected, and any errors). We use dbt for transformation testing where applicable, implementing data quality tests as code that run automatically with every pipeline execution. All pipeline validation is documented in a Pipeline Qualification Protocol with formal test scripts, expected results, and traceability to the data requirements specification.
Snowflake provides multiple audit trail mechanisms that collectively satisfy GxP audit trail requirements. Access History records every query executed against Snowflake, including the user, role, warehouse, query text, objects accessed, and timestamp — this is the primary audit trail for data access and is retained for 365 days in the ACCOUNT_USAGE schema. Login History tracks all authentication events including successful logins, failed attempts, and session details. Time Travel enables querying historical versions of data, showing what data looked like at any point within the retention window (up to 90 days), which serves as a change audit trail for data modifications. The QUERY_HISTORY view provides execution details including query duration, rows produced, and bytes scanned. For comprehensive GxP audit trail compliance, IntuitionLabs configures these features with appropriate retention periods, builds monitoring dashboards that flag anomalous access patterns, and implements archived audit log exports for long-term retention beyond Snowflake's built-in periods — satisfying the 21 CFR Part 11 §11.10(e) requirement for secure, computer-generated, time-stamped audit trails.
Snowflake does not provide a native electronic signature capability equivalent to wet-ink signature replacement as defined in 21 CFR Part 11 Subpart C. This is common for data platform technologies — they handle electronic records, not electronic signatures. For pharmaceutical use cases where formal electronic signatures are required (batch record approvals, document sign-off, deviation closures), the signature functionality is provided by upstream systems like Veeva Vault, MasterControl, or dedicated e-signature platforms, and the signed records flow into Snowflake as electronic records with their signature metadata preserved. Snowflake's authentication and access control framework does support the identity verification requirements that underpin electronic signatures — unique user accounts with MFA, SAML-based SSO, and session management — which means actions taken within Snowflake (queries, data modifications via approved pipelines) are attributable to authenticated individuals. IntuitionLabs documents this architectural boundary clearly in the validation package, specifying which Part 11 electronic signature requirements are met by upstream systems versus Snowflake, ensuring no compliance gaps exist across the integrated system landscape.
EU Annex 11 (Computerised Systems) overlaps significantly with 21 CFR Part 11 but includes additional requirements that Snowflake addresses. For risk management (Section 1), Snowflake's enterprise architecture with redundancy, encryption, and access controls provides a strong risk mitigation foundation. For supplier qualification (Section 3), Snowflake's SOC 2 Type II, ISO 27001, and GxP readiness attestation provide the evidence base for vendor qualification per GAMP 5 supplier assessment requirements. For data storage and backup (Section 7.2), Snowflake's continuous data protection (Time Travel + Fail-safe), cross-region replication, and encrypted storage satisfy backup and recovery requirements. For printout accuracy (Section 8.1), Snowflake's deterministic query execution ensures that the same query produces the same results, and exports can be validated as accurate representations of stored data. For change management (Section 10), Snowflake's behavior change management controls and our quarterly review SOPs address the requirement for change evaluation. For business continuity (Section 16), Snowflake's multi-availability-zone architecture and optional cross-region replication provide the disaster recovery capabilities required. IntuitionLabs maps all 17 sections of Annex 11 against Snowflake's capabilities in a formal Annex 11 Compliance Matrix, identifying controls, evidence, and any gaps requiring additional procedural or technical measures.
Validation timelines depend on the complexity of your Snowflake deployment and the breadth of GxP use cases. A focused validation of a single-domain Snowflake deployment (for example, a commercial analytics data warehouse with read-only analytical use) typically takes 6 to 10 weeks from kickoff through Validation Summary Report. A comprehensive validation of an enterprise Snowflake platform serving multiple GxP use cases — clinical data analytics, safety reporting, quality metrics, and commercial analytics — with multiple data pipelines and Cortex AI integrations spans 12 to 20 weeks. Our AI-accelerated approach reduces validation effort by automating documentation generation (test scripts, traceability matrices, compliance matrices), test execution for data pipeline validation, and audit trail review — typically reducing total validation effort by 30 to 40 percent compared to fully manual approaches. We phase validation to align with your deployment timeline: core platform validation first, followed by incremental validation of new data sources, pipelines, and AI capabilities as they are added. This phased approach enables earlier productive use of Snowflake while maintaining a validated state throughout the expansion.
Yes. Maintaining the validated state of a Snowflake environment requires continuous monitoring, not just initial validation. Our ongoing compliance monitoring service includes automated audit trail monitoring with alerts for anomalous access patterns, unauthorized data modifications, failed login attempts, and privilege escalation events; quarterly periodic reviews that assess Snowflake platform updates, configuration drift, and user access appropriateness against the validated baseline; annual revalidation assessments that determine whether accumulated changes require formal revalidation and execute targeted revalidation where needed; change control support providing impact assessments and validation documentation for planned changes (new data sources, pipeline modifications, AI workflow additions, user role changes); and regulatory intelligence monitoring that tracks updates to FDA guidance, EudraLex, and ICH guidelines that may affect your Snowflake compliance posture. This service is delivered as a managed retainer, typically paired with our broader managed application services for organizations that want a single partner managing both the technical operation and regulatory compliance of their Snowflake environment.
Ready to Validate Snowflake for GxP Use?
Ready to Validate Snowflake for GxP Use? image

Ready to Validate Snowflake for GxP Use?

Book a compliance assessment to evaluate your Snowflake deployment against 21 CFR Part 11, EU Annex 11, and GAMP 5 requirements. From gap assessment through IQ/OQ/PQ to ongoing compliance monitoring — we deliver the complete validation framework for regulated environments.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.